Use of a single silastic IV catheter for cystic fibrosis pulmonary exacerbations

Abstract

Use of a single percutaneous silastic IV catheter for cystic fibrosis hospitalizations was evaluated among 23 patients during 45 hospitalizations. Patient ages ranged from 4 to 20 years and weights from 18 to 60 kg. Percutaneous silastic catheters were used for infusion of all IV antibiotics and IV fluids. Catheters remained in place for a total of 549 patient days (mean 12.2, range 2–34). No patient demonstrated clinical signs of local infection or sepsis. Thirty six catheters served as the single IV access for a patient's entire hospitalization. Nine catheters were removed because of discomfort, obstruction, or mechanical dysfunction before the conclusion of the hospitalization. A single, percutaneously placed silastic catheter appears to be a safe and effective way of maintaining IV access throughout the duration of hospitalization for cystic fibrosis exacerbations.